This makes a lot of sense.
Very clearly, if the COH collab is being tied up, and surely to be included in the strategic review, dictating "quarter 3" really just allows for the timing to complete in a normal matter without naming a specific month.
What are everyone's thoughts - can we expect the Australian breast cancer trial to begin by end of this year / first quarter 2024? (If IV formulation is nearly done).
This makes a lot of sense.Very clearly, if the COH collab is...
-
- There are more pages in this discussion • 3,151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.075(4.53%) |
Mkt cap ! $294.8M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.73 | $1.64 | $271.9K | 161.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 3844 | 2 |
View Market Depth
| Last trade - 16.10pm 20/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |